Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employeeswho bringdifferent and innovativeways of seeing the world and solving problems.Fred Hutch is in pursuit of becoming an antiracist organization.Weare committed to ensuring that all candidates hired share our commitment to diversity,antiracism, and inclusion.
The Experimental Histopathology laboratory is recruiting a research Histotechnologist to provide routine and customized immunohistochemistry support for Fred Hutchinson research efforts.The incumbent will assist with the design of innovative protocols in a customer service based, team oriented work environment.
Perform routine immunohistochemistry on an automated platform and in situ hybridization, routine and special stains, and molecular studies.
Assist in the vetting of antibodies to be used for specific applications.
Assist in establishing, optimizing, and customizing histology procedures for fixing, processing, sectioning, staining, and reagent preparation to support immunohistochemistry projects.
Perform histology according to FDA (Food and Drug Administration) and GLP (Good Laboratory Practices) guidelines and regulations.
Research, troubleshoot, and test new reagents.
Optimize antigen retrieval conditions, blocking, detection, and titer to ensure ideal staining conditions for antibodies.
Work independently as an immunohistochemistry and histology resource for researchers to assist with preparation of their protocols.
Participate in group meetings with laboratory staff and researchers to discuss experimental design that will meet research goals.
Accurately log-in, label, organize, and track specimens.
Maintain inventory and order supplies, as necessary.
Prepare reagents from detailed laboratory procedures and document that quality control standards are being met.
Assist in the design and writing of laboratory protocols for all procedures.
Develop teaching and training materials and teach techniques to technicians, students, fellows, and other scientists.
Perform routine maintenance on immunohistochemistry, imaging, and other laboratory equipment.
Assist in organizing work and storage space and in general lab upkeep.
Perform routine and specialized histology support as needed
Remain current in the field by completing at least 10 hours of continuing education a year.
Perform other duties, as assigned.
The minimum requirement is a bachelors degree with 5years of relevant Histology/Pathology experience including 3 years in IHC. HT or HTL (ASCP) Certification plus one additional certification in immunohistochemistry, molecular pathology, or necropsy or demonstrate mastery of technique.
The successful technologist must be able to work accurately and efficiently, be detail oriented, and work both independently and within a group.
Strong troubleshooting and problem solving skills are required.
This position requires excellent written and verbal communication skills and the ability to work positively in a customer oriented environment. In addition, the incumbent must be flexible and skilled at organizing and prioritizing tasks.
Familiarity with Microsoft Word, Excel, SharePoint, and Internet Explorer is desirable.
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations. As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.